Powerful psychotropic drugs are often the next step, even though their combined effects in young children haven’t been ...

In April, J&J completed the acquisition of Intra-Cellular Therapies, which develops neuroscience drugs to treat conditions ...

If this neuromorphic machine is real, it’s a milestone for neuroscience—and a test of what AI can and can’t replace.

Though healthcare stocks have been much more measured this year, there are bright spots there as well. The medical-device maker Medtronic (MDT) closed at its highest price since May 12, 2022, after ...

Agios reported mixed results from a Phase 3 study of its drug Pyrukynd in sickle cell, raising doubts about the drug's ...

Lilly's tirzepatide is sold as Mounjaro for Type 2 diabetes and as Zepbound for weight loss -- but doctors have prescribed ...

President Sheinbaum is walking a tightrope between firmness and patience to dodge the US leader’s recurring proposal to send ...